Why Physical Activity Should Be Considered in Clinical Trials for COVID-19 Vaccines: A Focus on Risk Groups

Since the World Health Organization declared the global COVID-19 state of emergency in early 2020, several vaccine candidates have emerged to control SARS-CoV-2, and some of them have been approved and implemented in vaccination campaigns worldwide. Although clinical trials for these vaccines have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bortolini, Miguel Junior Sordi, Petriz, Bernardo, Mineo, José Roberto, Resende, Rafael de Oliveira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834774/
https://www.ncbi.nlm.nih.gov/pubmed/35162875
http://dx.doi.org/10.3390/ijerph19031853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834774/
https://www.ncbi.nlm.nih.gov/pubmed/35162875
http://dx.doi.org/10.3390/ijerph19031853

Ejemplares similares